NASH: The next untapped pharma market gives investors many options

NASH: The next untapped pharma market gives investors many options - Hallo friend NEWS AN INSPIRATION, In the article you read this time with the title NASH: The next untapped pharma market gives investors many options, we have prepared well for this article you read and download the information therein. hopefully fill posts Article ECONOMY, Article HEALTH, Article POLITICS, Article SPORTS, Article TRAVELING, Article UPDATE, we write can understand. Well, happy reading.

Titre : NASH: The next untapped pharma market gives investors many options
link : NASH: The next untapped pharma market gives investors many options

Read also


NASH: The next untapped pharma market gives investors many options

Drugmakers are taking a wide range of approaches to treat the complex disease, given multiple health issues among NASH patients that contribute to the liver damage, such as heart disease and diabetes. There are drugs targeting inflammation to prevent or reduce fibrotic scarring. Some address lipid regulation to reduce liver fat, while others attempt to directly halt or reverse fibrosis. And some companies are testing diabetes treatments to assess their ability to also improve NASH.

NASH: The next untapped pharma market gives investors many options
By Bill Berkrot
Large drugmakers with piles of cash are on the hunt for promising medicines being developed by small companies to treat NASH, a progressive fatty liver disease poised to become the leading cause of liver transplants by 2020.   

Pfizer currently has three early-stage drugs in the clinic aiming to block or reverse fat accumulation in the liver. "We believe that even though we're a bit behind, we still might come out with the best-in-class molecules," Birnbaum said.
    
Bristol-Myers Squibb (BMY.N) also confirmed it is looking for additional assets to enhance its internally-developed NASH drugs. It presented promising data for its lead NASH candidate at the big European liver meeting in Amsterdam that ended on Sunday.
Continue reading....


Thus articles NASH: The next untapped pharma market gives investors many options

that is all articles NASH: The next untapped pharma market gives investors many options This time, hopefully can provide benefits to you all. Okay, see you in another article post.

You are now reading the article NASH: The next untapped pharma market gives investors many options the link address https://newsaninpiration.blogspot.com/2017/04/nash-next-untapped-pharma-market-gives.html

Subscribe to receive free email updates:

0 Response to "NASH: The next untapped pharma market gives investors many options"

Post a Comment